642 related articles for article (PubMed ID: 29275471)
1. Oncolytic Virotherapy and the Tumor Microenvironment.
Berkey SE; Thorne SH; Bartlett DL
Adv Exp Med Biol; 2017; 1036():157-172. PubMed ID: 29275471
[TBL] [Abstract][Full Text] [Related]
2. Integrating oncolytic viruses in combination cancer immunotherapy.
Bommareddy PK; Shettigar M; Kaufman HL
Nat Rev Immunol; 2018 Aug; 18(8):498-513. PubMed ID: 29743717
[TBL] [Abstract][Full Text] [Related]
3. Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy.
Zhang B; Cheng P
Mol Cancer; 2020 Nov; 19(1):158. PubMed ID: 33172438
[TBL] [Abstract][Full Text] [Related]
4. Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy.
Achard C; Surendran A; Wedge ME; Ungerechts G; Bell J; Ilkow CS
EBioMedicine; 2018 May; 31():17-24. PubMed ID: 29724655
[TBL] [Abstract][Full Text] [Related]
5. Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study.
Marchini A; Daeffler L; Pozdeev VI; Angelova A; Rommelaere J
Front Immunol; 2019; 10():1848. PubMed ID: 31440242
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment.
Rosewell Shaw A; Suzuki M
Front Immunol; 2018; 9():2103. PubMed ID: 30298067
[TBL] [Abstract][Full Text] [Related]
7. Introduction to Oncolytic Virotherapy.
Engeland CE; Bell JC
Methods Mol Biol; 2020; 2058():1-6. PubMed ID: 31486028
[TBL] [Abstract][Full Text] [Related]
8. Multidirectional Strategies for Targeted Delivery of Oncolytic Viruses by Tumor Infiltrating Immune Cells.
Osali A; Zhiani M; Ghaebi M; Meymanat M; Esmaeilzadeh A
Pharmacol Res; 2020 Nov; 161():105094. PubMed ID: 32795509
[TBL] [Abstract][Full Text] [Related]
9. Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses.
Crupi MJF; Bell JC; Singaravelu R
Stem Cells; 2019 Jun; 37(6):716-723. PubMed ID: 30875126
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy.
Ghasemi M; Abbasi L; Ghanbari Naeini L; Kokabian P; Nameh Goshay Fard N; Givtaj N
Front Immunol; 2022; 13():950079. PubMed ID: 36703982
[TBL] [Abstract][Full Text] [Related]
11. The oncolytic virus ΔPK has multimodal anti-tumor activity.
Aurelian L; Bollino D; Colunga A
Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27242376
[TBL] [Abstract][Full Text] [Related]
12. Systemic delivery of glycosylated-PEG-masked oncolytic virus enhances targeting of antitumor immuno-virotherapy and modulates T and NK cell infiltration.
Liang Y; Wang B; Chen Q; Fu X; Jiang C; Lin Z; Zhuang Q; Zeng Y; Liu X; Zhang D
Theranostics; 2023; 13(15):5452-5468. PubMed ID: 37908722
[No Abstract] [Full Text] [Related]
13. Oncolytic viruses: focusing on the tumor microenvironment.
de Vries CR; Kaufman HL; Lattime EC
Cancer Gene Ther; 2015 Mar; 22(4):169-71. PubMed ID: 25721204
[No Abstract] [Full Text] [Related]
14. Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer.
Francis L; Guo ZS; Liu Z; Ravindranathan R; Urban JA; Sathaiah M; Magge D; Kalinski P; Bartlett DL
Oncotarget; 2016 Apr; 7(16):22174-85. PubMed ID: 26956047
[TBL] [Abstract][Full Text] [Related]
15. Strategies for enhancing intratumoral spread of oncolytic adenoviruses.
Goradel NH; Negahdari B; Ghorghanlu S; Jahangiri S; Arashkia A
Pharmacol Ther; 2020 Sep; 213():107586. PubMed ID: 32479843
[TBL] [Abstract][Full Text] [Related]
16. Impact of tumor microenvironment on oncolytic viral therapy.
Wojton J; Kaur B
Cytokine Growth Factor Rev; 2010; 21(2-3):127-34. PubMed ID: 20399700
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulation in Oncolytic Measles Virotherapy.
Dietz L; Engeland CE
Methods Mol Biol; 2020; 2058():111-126. PubMed ID: 31486034
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic Viruses: Therapeutics With an Identity Crisis.
Breitbach CJ; Lichty BD; Bell JC
EBioMedicine; 2016 Jul; 9():31-36. PubMed ID: 27407036
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic Viruses: Priming Time for Cancer Immunotherapy.
Russell L; Peng KW; Russell SJ; Diaz RM
BioDrugs; 2019 Oct; 33(5):485-501. PubMed ID: 31321623
[TBL] [Abstract][Full Text] [Related]
20. The Multifaceted Role of Macrophages in Oncolytic Virotherapy.
Hofman L; Lawler SE; Lamfers MLM
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]